Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

BioSpectrum Asia: “Moving forward, cancer may not be a death threat but a manageable disease with strong control”

By Christine Filippis / November 6, 2024
Cartherics’ CEO, Prof. Alan Trounson was recently interviewed by BioSpectrum Asia discussing the development of the company’s cell-based immunotherapies for...
Read More

Cartherics is “Frocking Up” this month to support ovarian cancer research

By Christine Filippis / October 30, 2024
Cartherics is frocking up this October to raise funds and awareness for crucial ovarian cancer research. The current five-year survival...
Read More

Cartherics raises over $15 Million in oversubscribed private financing round to advance cell therapy programs

By Christine Filippis / October 1, 2024
Financing round was significantly oversubscribed by existing investors and new private investors. Funding will enable the Company to progress clinical...
Read More
1 2 3 61